Evidence map›Paper›PMID 32182160›Full record

ArticleOmics : a journal of integrative biology2020

Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.

Gajanan Sathe, Kiran Kumar Mangalaparthi, Ankit Jain, Jacqueline Darrow, Juan Troncoso, Marilyn Albert, Abhay Moghekar, Akhilesh Pandey

Open access · greenAbstract read
In one paragraph

Article in Omics : a journal of integrative biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Gajanan SatheCenter for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Kiran Kumar MangalaparthiInstitute of Bioinformatics, Bangalore, India.
Ankit JainInstitute of Bioinformatics, Bangalore, India.
Jacqueline DarrowDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Juan TroncosoDepartment of Pathology and Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Marilyn AlbertDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abhay MoghekarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Akhilesh PandeyCenter for Molecular Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Johns Hopkins University · USInstitute of Bioinformatics · INMayo Clinic · US

Funding

Project 2 MeasurementU19AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI Mei Cheng Wang · 2014 to 2026
$51.5M
Understanding Mechanisms of a-synuclein pathologyP50NS038377 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DAWSON, TED M. · 1998 to 2019
$38.8M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
NIA NIH HHS P30 AG066507NIA NIH HHS U19 AG033655NINDS NIH HHS P50 NS038377
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder caused by neuronal loss that results in cognitive and functional impairment. Formation of neurofibrillary tangles composed of abnormal hyperphosphorylation of tau protein is one of the major pathological hallmarks of AD. Importantly, several neurodegenerative disorders, including AD, are associated with abnormal protein phosphorylation events. However, little is known thus far on global protein phosphorylation changes in AD. We report a phosphoproteomics study examining the frontal gyrus of people with AD and age-matched cognitively normal subjects, using tandem mass tag (TMT) multiplexing technology along with immobilized metal affinity chromatography to enrich phosphopeptides. We identified 4631 phosphopeptides corresponding to 1821 proteins with liquid chromatography-mass spectrometry (MS)/MS analysis on an Orbitrap Fusion Lumos Tribrid mass spectrometer. Of these, 504 phosphopeptides corresponding to 350 proteins were significantly altered in the AD brain: 389 phosphopeptides increased whereas 115 phosphopeptides decreased phosphorylation. We observed significant changes in phosphorylation of known as well as novel molecules. Using targeted parallel reaction monitoring experiments, we validated the phosphorylation of microtubule-associated protein tau and myristoylated alanine-rich protein kinase C substrate (MARCKS) in control and AD (Control = 6, AD = 11) brain samples. In conclusion, our study provides new evidence on alteration of RNA processing and splicing, neurogenesis and neuronal development, and metabotropic glutamate receptor 5 (GRM5) calcium signaling pathways in the AD brain, and it thus offers new insights to accelerate diagnostics and therapeutics innovation in AD.

Indexed as

Aged, 80 and overAlzheimer DiseaseAutopsyCase-Control StudiesFemaleGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansMaleMyristoylated Alanine-Rich C Kinase SubstrateNeurofibrillary TanglesPhosphoproteinsPhosphorylationPrefrontal CortexProteomeGRM5 protein, humanMARCKS protein, humanMyristoylated Alanine-Rich C Kinase SubstratePhosphoproteinsProteomeReceptor, Metabotropic Glutamate 5Alzheimer's diseasebiomarkersdementiadiagnosticsmultiplexingneurosciencephosphorylationproteomics

Identifiers

PMID32182160
PMCPMC7366319
OpenAlexW3012247136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.